Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

411 Press Releases
DateTitleCompany
24 Feb 16 Teva Pharmaceuticals Embarks on Strategic Corporate Identity Program to Build a Global Brand Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
11 Feb 16 Teva Files 2015 Annual Report on Form 20-F Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Feb 16 Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Jan 16 Teva to Report Fourth Quarter 2015 Financial Results on February 11, 2016 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Jan 16 Teva Releases Innovation and Social Responsibility Highlights Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Jan 16 Teva and Checkpoint Therapeutics Announce License Agreement for Oral PARP Inhibitor Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Jan 16 Teva to Present at the 34th Annual J.P. Morgan Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Jan 16 Teva Announces Launch of Generic Ortho Tri-Cyclen® Lo in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
04 Jan 16 Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Jan 16 Teva Announces Exercise of Underwriters’ Over-Allotment Option Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Dec 15 INSERTING and REPLACING Takeda Provides Further Information about its New Business Venture with Teva Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Dec 15 Takeda Provides Further Information about its New Business Venture with Teva Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Dec 15 FDA Advisory Committee Recommends Approval of Teva’s Asthma Biologic Reslizumab Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Dec 15 Teva Announces Closing of Public Offerings of American Depositary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Actavis Generics Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Dec 15 Teva Pharmaceuticals and Eagle Pharmaceuticals Announce FDA Approval of BENDEKA™ (bendamustine hydrochloride) Injection Teva Pharmaceutical Industries Ltd. and Eagle Pharmaceuticals, Inc.,
Published by
Business Wire
03 Dec 15 Teva Announces Pricing of Public Offerings of American Depositary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Actavis Generics Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Nov 15 Teva Announces Proposed Public Offerings of American Depositary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Actavis Generics Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Nov 15 Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Sep 15 Teva Announces Approval of COPAXONE® in Japan for the Prevention of Relapse of Multiple Sclerosis Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 Nov 15 Teva Announces Breakthrough Therapy Designation for SD-809 Granted by FDA for the Treatment of Tardive Dyskinesia Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Nov 15 Teva to Present at the Jefferies Autumn 2015 Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
19 Nov 15 Teva Reports Positive Top-Line Results from Phase III Trials Evaluating Fluticasone Propionate/Salmeterol and Fluticasone Propionate Multidose Dry Powder Inhalers (MDPIs) in Patients with Asthma Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Nov 15 Teva and Heptares Enter Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of Migraine Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 Sep 15 Teva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Sep 15 Important New Data from Teva's TEV-48125 Phase 2B Migraine Program Published in Lancet Neurology in Back-to-Back Articles Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Oct 15 Teva to Host Third Quarter 2015 Financial Results Conference Call and Webcast on October 29, 2015 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Oct 15 Teva Announces Exclusive Launch of Generic Avodart® Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Oct 15 Teva Accelerates its Emerging Markets Growth Strategy with the Acquisition of Rimsa, a Leading Independent Pharmaceutical Company in Mexico with a Portfolio of Products and Patents in Latin America Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Oct 15 Teva Reinforces Focus on Advancing Multiple Sclerosis Treatment at 31st ECTRIMS Congress Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Oct 15 Teva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of Relapsing-Remitting Multiple Sclerosis Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.